Cucurbitacin B, a novel in vivo potentiator of gemcitabine with low toxicity in the treatment of pancreatic cancer
British Journal of Pharmacology
Saved in:
Main Authors: | Iwanski, G.B., Lee, D.H., En-Gal, S., Doan, N.B., Castor, B., Vogt, M., Toh, M., Bokemeyer, C., Said, J.W., Thoennissen, N.H., Koeffler, H.P. |
---|---|
Other Authors: | MEDICINE |
Format: | Article |
Published: |
2015
|
Subjects: | |
Online Access: | http://scholarbank.nus.edu.sg/handle/10635/120856 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Synergistic effect of low-dose cucurbitacin B and low-dose methotrexate for treatment of human osteosarcoma
by: Lee, D.H., et al.
Published: (2016) -
The triterpenoid cucurbitacin B augments the antiproliferative activity of chemotherapy in human breast cancer
by: Aribi, A., et al.
Published: (2016) -
Cucurbitacin induces autophagy through mitochondrial ROS production which counteracts to limit caspase-dependent apopt
by: Zhang, T., et al.
Published: (2014) -
Does saturable formation of gemcitabine triphosphate occur in patients?
by: Tham, L.-S., et al.
Published: (2014) -
Leptin as a neuroprotective agent
by: Tang, B.L.
Published: (2011)